Immuno-oncology Ona, Biocytogen enter agreement for antibody-drug conjugates Dec. 18, 2023 No Comments Biocytogen Pharmaceuticals (Beijing) Co. Ltd. has entered into an antibody evaluation, option and license agreement with Ona Therapeutics SL.Read More
Ona takes on cancer metastases, raises $34M in series A June 16, 2020 By Nuala Moran No Comments LONDON - Ona Therapeutics SL has raised €30 million (US$33.9 million) in a series A round, providing the means to advance a new method of treating metastases by blocking the lipid metabolism of cancer cells.Read More